Evaluation of in vitro release kinetics 51
Evaluation of Nevirapine Release Kinetics from Polycaprolactone Hybrids
... the release data, since this model presented the highest coefficient correlation (r) ...drug release probably oc- cur by diffusion through the matrix pores, thus, these materials are suitable for sus- ...
22
IN VITRO RELEASE KINETICS STUDY OF TRAMADOL HCl SUSTAINED RELEASE MATRIX TABLET FROM HPMC K15M
... Physical evaluation of Granules: 1. Bulk density: The bulk density of a powder is dependent on particle packing and changes as the powder consolidates. A consolidated powder is likely to have a greater arch ...
7
TRANSDERMAL DELIVERY OF FENOPROFEN: PREPARATION, EVALUATION AND IN VITRO RELEASE
... describing release with kinetic values ranging between ...drug release followed zero order kinetics and was found to be diffusion controlled, non-fickian ...
12
EVALUATION OF THE RELEASE OF ASCORBIC ACID IN PROLONGED-RELEASE TABLETS BY IN VITRO DISSOLUTION TESTS
... in vitro dissolution tests were performed in a dissolver with a paddle apparatus at a temperature of 37°C (± ...prolonged release of ascorbic ...time. Release kinetics was evaluated using ...
9
Formulation and evaluation of gastroretentive tablets of Furosemide (Evaluation based on drug release kinetics and factorial designs)
... In vitro drug release study was performed using USP XXIII dissolution test apparatus-II at 50 rpm using 900 ml of ...drug release in 10 hours decreases, and as the proportion of the gas generating ...
44
Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC
... Experimental batches were validated to confirm the accuracy and reproducibility of physical and chemical characteristics. Mixing time was validated by performing content uniformity tests for ibuprofen in the blend at ...
6
Formulation and In Vitro Evaluation of Controlled Release Matrix Tablets of Isradipine.
... penetrated solvent, so that the polymer chains become more flexible and the matrix swells. This allows the encapsulated drug to diffuse more rapidly out of the matrix. On the other hand, it would take more time for drug ...
108
Sustained Release Suppositories of Metoclopramide HCl: Formulation and In vitro Evaluation
... sustained release suppositories were formulated with the different ratios of release modifier by fusion ...In vitro release experiments were conducted on the prepared ...drug release ...
7
FORMULATION AND IN-VITRO EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF LEVOFLOXACIN
... sustained release matrix tablets of levofloxacin to achieve sustained drug release with reduced side effects and improved patient ...sustained release matrix tablets of levofloxacin were prepared by ...
9
Formulation and In-Vitro Evaluation of Metformin Hydrochloride Sustained Release Tablets
... sustained release of metformin hydrochloride from ...drug release data were subjected to different models in order to evaluate release kinetics and mechanism of drug ...order kinetics ...
6
FORMULATION AND IN-VITRO EVALUATION OF METFORMIN SUSTAINED RELEASE MATRIX TABLETS
... drug release kinetics is carried out at pH ...the release rate of Met better than all other combinations. In-vitro release kinetic study carried out for all the formulations and ...
8
Formulation and in vitro evaluation of bosentan osmatic controlled release tablets
... In vitro Evaluation of Bosentan Osmotic Controlled Release Tablets” was ...controlled release was studied. The release kinetics, dissolution rate, process variables such as ...
9
Poloxamer-based binary hydrogels for delivering tramadol hydrochloride: sol-gel transition studies, dissolution-release kinetics, in vitro toxicity, and pharmacological evaluation
... PL 407 and PL 188, as binary systems can be an interesting alternative to modulate the biopharmaceutical profile of these formulations. 8–11 The use of PL has been reported in the literature spe- cifically for pain ...
11
Evaluation of In-Vitro Release Kinetic and
... a slow sustained kinetic release pattern of curcumin from the core shell of CSCaCO 3 NP as compared. 456[r] ...
33
DESIGN DEVELOPMENT AND IN VITRO EVALUATION CONTROLLED RELEASE TABLETS
... sustained release dosage forms involves the direct compression of the blends of drug, retardant material and additives to form a tablet in which the drug is embedded in a matrix core of the ...
6
Formulation and in vitro evaluation of modified release Gliclazide tablet
... modified release gliclazide once a daily tablet were designed for non-insulin dependent diabetes for better patient compliance by direct compression method, HPMC was used as polymer, Dibasic calcium phosphate and ...
5
DESIGN AND IN VITRO EVALUATION OF SUSTAINED RELEASE TABLETS OF RANOLAZINE
... in vitro release of Ranolazine SR tablets was studied in 900 ml of ...better release of 99.78±0.99% after 24 hours. It showed Zero-order release with linearity ...
7
FORMULATION AND IN-VITRO EVALUATION OF PULSATILE RELEASE OF DILTIAZEM HYDROCHLORIDE
... the release of drug and grant a new lease on life to a drug molecule in terms of ...formulation release drug rapidly and completely as a pulse after a lag ...Pulsatile release formulation develop for ...
7
DESIGN AND IN VITRO EVALUATION OF EXTENDED RELEASE TABLET OF NATEGLINIDE
... extended release matrix tablet of Nateglinide by direct compression method using different polymer like HPMC K4 and HPMC ...in vitro drug release ...drug release up to 12 ...in-vitro ...
5
Formulation and In-vitro evaluation of immediate release Olanzapine tablets
... . The main objective of the present study was to formulate stable immediate release Olanzapine tablets matching in invitro dissolution with the marketed formulation. Olanzapine is hygroscopic and sensitive to heat ...
12